1 active not recruiting, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Withdrawn 1 |
Follow Cancer, Advanced: new trials by email Literature Review of Cancer, Advanced trials Research Report on Cancer, Advanced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Histology-Independent Study of Palbociclib in Patients With Advanced Cancer Palbociclib 125mg - Cancer, Advanced | Phase 2 | Withdrawn | Razelle Kurzrock, MD | 2018-07-01 | 2018-06-21 | |
| Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer Pembrolizumab, Radiation therapy, Cisplatin - Head and Neck Squamous Cell Carcinoma, Cancer | Phase 2 | Active not recruiting | Loren Mell, MD | 126 | 2018-03-15 | 2025-10-07 |
Neoplasms (2) · Head and Neck Neoplasms (1) · Mouth Neoplasms (1) · Neoplasm Metastasis (1) · Oropharyngeal Neoplasms (1) · Parkinson Disease 4, Autosomal Dominant Lewy Body (1) · Recurrence (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma (1) · Carcinoma, Squamous Cell (1) · Disease Attributes (1) · Mouth Diseases (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplastic Processes (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pharyngeal Diseases (1) · Pharyngeal Neoplasms (1) · Stomatognathic Diseases (1)
Cisplatin (1) · Drug Therapy (1) · Immunotherapy (1) · Radiotherapy (1) · palbociclib (1) · pembrolizumab (1)
Loren Mell, MD (1) · Razelle Kurzrock, MD (1)
United States (2)
Loren Mell, MD (1) · Scott Lippman, MD (1)